SSA
BLFS icon

Schonfeld Strategic Advisors’s BioLife Solutions BLFS Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-26,300
Closed -$598K – 2604
2022
Q3 		$598K Buy
+26,300
New +$563K 0.01% 1622
2020
Q1 		– Sell
-11,400
Closed -$184K – 1160
2019
Q4 		$184K Sell
11,400
-73,000
-86% -$1.19M ﹤0.01% 1176
2019
Q3 		$1.4M Sell
84,400
-96,900
-53% -$1.82M 0.04% 393
2019
Q2 		$3.07M Sell
181,300
-93,900
-34% -$1.64M 0.11% 221
2019
Q1 		$4.92M Sell
275,200
-61,500
-18% -$978K 0.17% 158
2018
Q4 		$4.05M Sell
336,700
-31,800
-9% -$380K 0.16% 182
2018
Q3 		$6.45M Buy
368,500
+18,500
+5% +$366K 0.29% 97
2018
Q2 		$3.99M Hold
350,000
– – 0.22% 162
2018
Q1 		$1.8M Buy
350,000
+14,773
+4% +$80K 0.13% 216
2017
Q4 		$2.01M Buy
335,227
+45,227
+16% +$261K 0.16% 172
2017
Q3 		$1.66M Buy
290,000
+190,000
+190% +$788K 0.15% 174
2017
Q2 		$239K Buy
+100,000
New +$218K 0.02% 525

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Schonfeld Strategic Advisors's BLFS Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of BioLife Solutions (BLFS) in Q4 2022, closing a stake of 26,300 shares — an estimated $598K sold.

Schonfeld Strategic Advisors first reported a position in BLFS in Q2 2017 and held it in 12 quarters. The position peaked at $6.45M in Q3 2018. 165 funds tracked by Wall St. Rank hold BLFS as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining BioLife Solutions position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 26,300 BioLife Solutions shares in Q4 2022, an estimated $598K.
  • Schonfeld Strategic Advisors first reported a position in BioLife Solutions in Q2 2017 and held it in 12 quarters.
  • Schonfeld Strategic Advisors's BioLife Solutions position peaked at $6.45M in Q3 2018.
  • 165 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.